Hann Christopher E, Revie James A, Hewett Darren, Chase J Geoffrey, Shaw Geoffrey M
University of Canterbury, Centre for Bio-Engineering, Department of Mechanical Engineering, Christchurch, New Zealand.
J Diabetes Sci Technol. 2009 Jul 1;3(4):819-34. doi: 10.1177/193229680900300431.
Hyperglycemia and diabetes result in vascular complications, most notably diabetic retinopathy (DR). The prevalence of DR is growing and is a leading cause of blindness and/or visual impairment in developed countries. Current methods of detecting, screening, and monitoring DR are based on subjective human evaluation, which is also slow and time-consuming. As a result, initiation and progress monitoring of DR is clinically hard.
Computer vision methods are developed to isolate and detect two of the most common DR dysfunctions-dot hemorrhages (DH) and exudates. The algorithms use specific color channels and segmentation methods to separate these DR manifestations from physiological features in digital fundus images. The algorithms are tested on the first 100 images from a published database. The diagnostic outcome and the resulting positive and negative prediction values (PPV and NPV) are reported. The first 50 images are marked with specialist determined ground truth for each individual exudate and/or DH, which are also compared to algorithm identification.
Exudate identification had 96.7% sensitivity and 94.9% specificity for diagnosis (PPV = 97%, NPV = 95%). Dot hemorrhage identification had 98.7% sensitivity and 100% specificity (PPV = 100%, NPV = 96%). Greater than 95% of ground truth identified exudates, and DHs were found by the algorithm in the marked first 50 images, with less than 0.5% false positives.
A direct computer vision approach enabled high-quality identification of exudates and DHs in an independent data set of fundus images. The methods are readily generalizable to other clinical manifestations of DR. The results justify a blinded clinical trial of the system to prove its capability to detect, diagnose, and, over the long term, monitor the state of DR in individuals with diabetes.
高血糖和糖尿病会导致血管并发症,其中最显著的是糖尿病视网膜病变(DR)。DR的患病率正在上升,并且是发达国家失明和/或视力损害的主要原因。目前检测、筛查和监测DR的方法基于主观的人工评估,这种评估既缓慢又耗时。因此,DR的发病和进展监测在临床上具有难度。
开发了计算机视觉方法来分离和检测DR最常见的两种功能障碍——点状出血(DH)和渗出物。该算法使用特定的颜色通道和分割方法,将这些DR表现与数字眼底图像中的生理特征区分开来。该算法在一个已发表数据库的前100张图像上进行了测试。报告了诊断结果以及由此得出的阳性和阴性预测值(PPV和NPV)。前50张图像由专家针对每个渗出物和/或DH确定了真实情况标记,这些标记也与算法识别结果进行了比较。
渗出物识别诊断的灵敏度为96.7%,特异性为94.9%(PPV = 97%,NPV = 95%)。点状出血识别的灵敏度为98.7%,特异性为100%(PPV = 100%,NPV = 96%)。在标记的前50张图像中,算法发现超过95%的真实情况确定的渗出物和DH,假阳性率低于0.5%。
一种直接的计算机视觉方法能够在眼底图像的独立数据集中高质量地识别渗出物和DH。这些方法很容易推广到DR的其他临床表现。研究结果证明有必要对该系统进行盲法临床试验,以证明其检测、诊断以及长期监测糖尿病患者DR状态的能力。